Save time and get answers to complex questions with AI chat
Defense strategy against generic in niche market?Abbvie humira patent cliff navigation success?Albendazole side effects in humans?Combivent inhaler hfc 152a patents?When is tenofovir alafenamide patent expiring?
See the DrugPatentWatch profile for Auvelity
Auvelity is a prescription antidepressant that combines two active ingredients: dextromethorphan and bupropion [1].
Auvelity pairs: - Dextromethorphan, which is an NMDA receptor antagonist [1]. - Bupropion, which is a norepinephrine-dopamine reuptake inhibitor (NDRI) [1].
People often want to know whether Auvelity contains the same drugs as other products. Because it is a fixed-dose combination of dextromethorphan plus bupropion, it overlaps with both: - Dextromethorphan products (a common ingredient in cough medicines) and - Bupropion products (sold separately as antidepressants and for smoking cessation) [1]. Sources [1] https://www.drugpatentwatch.com/patent/auvelity
Other Questions About Auvelity :